Comparing a new eye drop to a standard one for glaucoma and high eye pressure
Part of Eyes & vision clinical trials.
This study tests a new eye drop against an existing one to see which better lowers eye pressure in people with open-angle glaucoma or ocular hypertension. You may be able to join if you have high eye pressure in both eyes that needs treatment and you are at least 18 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary open-angle glaucoma or ocular hypertension (high eye pressure) in both eyes.
- You are at least 18 years old.
- Your eye pressure is between 22 and 34 mm Hg in both eyes, with a difference of no more than 5 mm Hg between them.
- You can stop using other eye pressure-lowering drops for a washout period before starting the study.
- You do not have other significant eye diseases, eye infections, or a history of certain eye surgeries.
- If you can get pregnant, you must use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HUC3-637 for people with primary open-angle glaucoma or ocular hypertension. It aims to see if it safely lowers eye pressure.
This trial tests an investigational drug called REGN22530 for people with mild to moderate primary open-angle glaucoma or ocular hypertension (high eye pressure). The goal is to see if it can safely lower eye pressure and protect vision.
This trial tests whether a new formulation of bimatoprost works as well as an existing one to lower eye pressure in people with chronic open-angle glaucoma or ocular hypertension. It involves multiple eye drop doses and checks for safety and effectiveness.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
This trial tests a new device that measures eye pressure without touching the eye. It may help people with or without glaucoma by making it easier to check eye pressure regularly.
This study tests a new eye drop medicine (DNN.31.19.026) to lower pressure inside the eye for people with glaucoma or ocular hypertension. The goal is to see if it works safely when combined with other eye pressure medications.
Hear when a new Primary Open Angle Glaucoma (POAG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.